A step forward in characterization capabilities within the extracellular vesicle (EV) field. The fully automated platform provides multi-level and comprehensive EV measurements for particle size analysis, EV count, EV phenotype, and biomarker colocalization. The ExoView™ platform provides previously unattainable information in a single, bias and purification free sample workflow.
ExoView™: Complete Characterization of Exosomes and Extracellular Vesicles (EVs)
ExoView™ bridges the gap between the requirements of the EV researcher and the capabilities of existing analytical equipment. ExoView™ measures direct from sample without the need to purify, and provides multiplexed analysis of EVs size, count, and phenotype without the need for fluorescence labels. Eliminating the need for purification and labeling removes many of the biases associated with sample preparation. ExoView™ provides critical information that will assist in the translation of EV research into the clinical and therapeutic environments.
Complete Characterization of Exosomes and Extracellular Vesicles (EVs)
Colocalize markers using fluorescence to identify sub-populations expressing multiple markers
Count the number of antigen-positive EVs directly from sample with no purification
Measure the size of individual, antigen-positive EVs with high resolution
PURIFICATION NOT REQUIRed
Measure the changes in your sample, not the biases from your purification technique
Multiplexed sample analysis
Capture can characterize multiple populations of EVs from a single sample using many surface markers
Automated instrument measurement and parallel sample preparation reduces hands-on time and increases sample throughput
Range of validated capture antibodies available. Custom assays are also available
Detect and characterize EVs using many surface markers from a single sample. Link phenotypic information to the size and count single EVs with no purification required.
Purification Not Required
Purification techniques are broadly based on density, size, or precipitation, however, contaminants with similar size or density are indistinguishable from EVs. When looking for rare events or subtle changes in EV sub-populations, the variability and biases introduced through purification may limit biological understanding.
ExoView eliminates biases by bypassing sample purification, and fully characterizes EVs direct from biological samples with high specificity, in low volumes, and with superior detection sensitivities.
NanoView Biosciences has assembled an experienced team of technical, commercial, and industry experts. We have a wealth of experience within the extracellular vesicles field, and the broader diagnostic and life sciences markets. We are keen to engage with customers at all levels, so please feel free to get in touch with us to discuss your projects and research. We'd love to hear from you!